Zobrazeno 1 - 10
of 40
pro vyhledávání: '"M I, Karelin"'
Autor:
O. B. Karyakin, B. P. Matveev, V. B. Matveev, I. G. Rusakov, O. B. Loran, Ye. I. Veliyev, L. V. Shaplygin, B. V. Bukharkin, V. A. Biryukov, N. G. Minayeva, A. A. Atayev, V. M. Shelepova, M. I. Karelin, D. G. Prokhorov, Yu. N. Khrizman, V. K. Shakurov, E. F. Abdrakhmanov, V. N. Zhuravlev, A. V. Zyryanov, V. O. Mager, P. A. Karnaukh
Publikováno v:
Onkourologiâ, Vol 3, Iss 2, Pp 56-60 (2020)
Introduction: Hormonal therapy is the method of choice in treating disseminated prostate cancer. Chronic androgenic suppression causes a reduction in bone mineral density. The most common complications of bone metastases are pathological fractures, s
Publikováno v:
Onkourologiâ, Vol 4, Iss 3, Pp 63-66 (2020)
Objective. Prostate cancer incidence have been increasing over past decade and was estimated to be 17,8 per 100000 male in 2005. That year prostate cancer was the third most common male malignancy in Saint-Petersburg. The instrument «LigaSure» manu
Publikováno v:
Onkourologiâ, Vol 2, Iss 4, Pp 63-69 (2020)
Treatment policy for small renal tumors, up to 4 cm (T1a) varies from a follow-up to organ-removing operations. Renal resection is currently the standard of treatment. The basic principle of organ-preserving treatment is a maximally sparing attitude
Publikováno v:
Onkourologiâ, Vol 4, Iss 2, Pp 53-56 (2020)
Research purpose. Investigate possibilities of the transrectal ultrasonography (TRUS) in early diagnostics of the local recurrence of the prostate cancer (PC) following radical prostatectomy (RPE). Materials and methods. 50 PC patients at the age of
Publikováno v:
Onkourologiâ, Vol 2, Iss 2, Pp 61-63 (2020)
For patients with metastatic prostate cancer, palliative treatment is largely based on relief of skeletal pain. To evaluate a palliative effect and to reveal the positive and negative effects of a refresher course of systemic radiotherapy with stront
Publikováno v:
Современная онкология, Vol 6, Iss 1, Pp 30-31 (2004)
Успешное лечение инфильтративных форм рака мочевого пузыря (РМП) к настоящему времени остается нерешенной проблемой. Ее актуальность о
Externí odkaz:
https://doaj.org/article/96229c88326f4665960dc41142ec4f02
Autor:
O. E. Molchanov, M. I. Karelin
Publikováno v:
Onkourologiâ, Vol 5, Iss 4, Pp 13-18 (2014)
Objective: to assess a role of immunomonitoring in patients with disseminated renal-cell carcinoma. Subjects and methods. One hundred and seventy-five patients treated in 1998 to 2008 were followed up. The patients received various immunochemotherapy
Autor:
A. I. Urbanskii, K. Spikermann, Yu. P. Knyazev, Axel Ullrich, K. H. Bangma, Pjotr Knyazev, M. I. Shkolnik, Yu. V. Cheburkin, S. Peter, Evtushenko Vi, G. Jenster, M. I. Karelin
Publikováno v:
Molecular Biology. 37:89-101
Hybridization with cDNA arrays was used to obtain expression profiles of 263 protein-tyrosine kinase (PTK), protein-tyrosine phosphatase (PTP), dual-specific phosphatase (DuSP), and other genes for the normal prostate tissue, primary prostate carcino
Autor:
Evtushenko Vi, T. G. Knyazeva, Yu. V. Cheburkin, M. I. Karelin, M. I. Shkolnik, S. Peter, Hanson Kp, Axel Ullrich, Yu. P. Knyazev, Pjotr Knyazev
Publikováno v:
Molecular Biology. 36:376-384
Hybridization with cDNA arrays was used to obtain expression profiles of 214 protein-tyrosine kinase, protein-tyrosine phosphatase, dual specificity phosphatase, and other genes for kidney carcinomas (KC) and normal kidney tissues of 34 patients and
Publikováno v:
Voprosy onkologii. 57(6)